For many American companies, China is land of opportunity

Life Science

China National Drug Administration Approves Country’s First Immuno-Oncology Agent, Opdivo (nivolumab injection), for Previously Treated Non-Small Cell Lung Cancer (NSCLC)

Life Science

Blueprint Medicines Announces Updated Data from Ongoing Phase 1 EXPLORER Clinical Trial of Avapritinib in Patients with Advanced Systemic Mastocytosis Showing Profound and Durable Clinical Activity

Life Science

Aptose Acquires China Rights to Leukemia Candidate in $125 Million Agreement

Life Science

China to impose 25 pct tariffs on 659 U.S. goods worth $50 bln

Energy

SandRidge says approached by 17 potential buyers, including Icahn

Energy

U.S. agency asks judge to rule virtual currency is commodity

Technology

Chinese regulators approve Qualcomm purchase of NXP for US$44 billion, sources say

Technology

Johnson & Johnson Innovation Announces Launch of Shanghai Lung Cancer Innovation QuickFire Challenge

Life Science

Mevion Raises $150 Million from China Investors for Proton Therapy Machines

Life Science

Life Science & Technology Weekly 147 – Shanghai Kinetic Acquires US Device Maker Elliquence for $77 Million

Life Science, Technology

China and India Want to Buy More U.S. Oil to Counter OPEC

Energy

Eisai Plans Invests $100M in Genetics Guided Dementia Discovery Facility in Cambridge, Mass.

Life Science

An unlikely winner from the AT&T-Time Warner decision — CVS Health

Life Science

Preceptis Medical Announces Closing of Series B Financing

Life Science